New Insights into Cellular Survival Mechanisms in Nutrient-Deficient Conditions

UCLA scientists have uncovered how cells, including cancer cells, activate adaptive mechanisms involving MYC and chromatin changes to survive nutrient scarcity, opening new pathways for cancer treatment strategies.
Researchers at UCLA have revealed a remarkable strategy that cells, including cancer cells, employ to survive in environments with limited nutrients. Their study, recently published in Cancer & Metabolism, demonstrates that when amino acids—the building blocks for proteins and cell growth—are scarce, cells activate a key growth regulator called MYC. Simultaneously, they modify the chromatin structure by reducing a specific chemical mark known as H4K20me1 that typically covers active genes. These dual changes prepare the cell’s machinery for rapid protein synthesis once nutrients become available again, effectively priming the cell for recovery.
This adaptive mechanism partly explains how MYC-driven cancers, which often exhibit overactivation of the MYC gene, manage to survive and proliferate under metabolic stress. The team conducted experiments on human cells with and without amino acids, utilizing advanced molecular techniques to assess changes in gene expression and protein production. They found that reduced amino acid levels lead to a reprogramming of gene activity, especially in regions supporting protein synthesis.
Understanding this chromatin-based priming process opens new avenues for targeting cancer metabolism. By disrupting these adaptive strategies, it might be possible to develop therapies that make cancer cells more vulnerable when nutrients are scarce. Dr. Siavash Kurdistani, senior author of the study, emphasizes that recognizing how cells prepare for recovery under nutrient stress could help design new interventions for MYC-associated cancers and other diseases influenced by metabolic conditions.
This discovery highlights the resilience of cancer cells and underscores the importance of epigenetic regulation in cellular adaptation, paving the way for innovative treatments based on metabolic and chromatin remodeling mechanisms.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Research Finds Mitochondrial Protein Misfolding Contributes to Type 2 Diabetes Progression
Research reveals that misfolded proteins accumulating in mitochondria contribute to beta cell death in type 2 diabetes, offering new therapeutic targets.
Analysis Reveals Lack of Transparency and Penalties for Serious Errors in Rehab Hospitals
A recent analysis uncovers serious safety issues in rehab hospitals, including patient deaths and medication errors, with limited penalties and transparency from federal agencies. Learn about the risks and oversight gaps in this profitable industry.
AI Model Suggests Nearly 40% of Breast Cancer Patients Could Avoid Axillary Surgery
A groundbreaking AI model from Lund University predicts that nearly 40% of breast cancer patients could safely avoid axillary surgery, paving the way for more personalized and less invasive treatment strategies.
Increased Likelihood of Repeat Imaging When Nonphysician Practitioners Interpret Studies
A recent study shows that imaging studies interpreted by nonphysician practitioners have higher rates of being repeated within 90 days, raising questions about healthcare quality and efficiency.



